TrialBlood advances2025
Acquired mutations in patients with relapsed/refractory CLL who progressed in the ALPINE study.
Jennifer R Brown et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
8 papers cite it
this papercites it
TrialBlood advances2025
Jennifer R Brown et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.